AbbVie Completes Acquisition of Aliada Therapeutics

Estimated read time 1 min read

This acquisition will bring Aliada’s Alzheimer’s treatment under AbbVie’s pipeline.

You May Also Like

More From Author

+ There are no comments

Add yours